MRI在三阴性乳腺癌新辅助化疗疗效评价中的研究进展OA北大核心CSTPCD
Research progress of MRI in the evaluation of neoadjuvant chemotherapy efficacy for triple-negative breast cancer
三阴性乳腺癌(triple-negative breast cancer,TNBC)是一种具有高度异质性及侵袭性的乳腺癌亚型,并且由于缺乏有效的治疗靶点,对内分泌治疗及靶向治疗均不敏感,预后较差.目前新辅助化疗(neoadjuvant chemotherapy,NAC)是其标准治疗策略之一,但个体差异及肿瘤异质性使得不同患者的疗效差别较大,故早期准确客观评估NAC疗效对TNBC患者后续治疗的方案制订及预后判断尤为重要.磁共振成像(magnetic…查看全部>>
Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by high heterogeneity and aggressiveness. Because of the absence of effective therapeutic targets,TNBC is insensitive to endocrine therapy and targeted therapy,resulting in a poor prognosis. Currently,neoadjuvant chemotherapy (NAC) is one of the standard treatment strategies for TNBC. Given the individual variances and tumor heterogeneity,TNBC patients' response to NAC varies si…查看全部>>
李书念;谭红娜
郑州大学人民医院河南省人民医院医学影像科,郑州 450003郑州大学人民医院河南省人民医院医学影像科,郑州 450003
临床医学
乳腺肿瘤三阴性乳腺癌磁共振成像新辅助化疗疗效预测
breast cancertriple-negative breast cancermagnetic resonance imagingneoadjuvant chemotherapyefficacy prediction
《磁共振成像》 2024 (7)
191-195,5
河南省医学科技攻关计划项目(编号:LHGJ20220055) Medical Science and Technological Project of Henan Province(No.LHGJ20220055).
评论